UroIQ Exam Revision Series | Non-Muscle Invasive Bladder Cancer | Guidelines for Board Examinations

This video is part of the UroIQ Exam Revision Series, a structured programme designed to support urology trainees preparing for postgraduate examinations including the FRCS and international urology board certifications. This episode provides a comprehensive, guideline-based revision of Non-Muscle Invasive Bladder Cancer (NMIBC) with a clear, exam-focused framework. Key areas covered include: • Risk stratification and prognostic grouping • Indications for repeat TURBT • Intravesical chemotherapy and BCG protocols • Definitions of BCG failure and high-risk disease • Criteria for early radical cystectomy • Surveillance strategies and follow-up schedules The content is structured to help candidates organise answers logically for written, clinical, and viva examinations. This podcast-style revision format is designed for efficient learning during commutes, focused study sessions, or rapid pre-exam consolidation. About the Series The UroIQ Exam Revision Series delivers guideline-driven, high-yield urology topics presented in a concise and structured format to facilitate exam preparation and clinical understanding. Disclaimer This video is intended for educational purposes only. It is designed to support exam preparation and should not replace independent review of official guidelines or clinical judgement in patient care.